echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > A protein family is expected to be a treatment for ischemic stroke

    A protein family is expected to be a treatment for ischemic stroke

    • Last Update: 2021-09-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Interalpha inhibitor proteins (IAIP) is a family of structurally related proteins, which are mainly produced in the liver, exist in high concentrations in plasma, and have a wide range of anti-inflammatory activities


    Dr.


    Ischemic stroke accounts for 80% to 85% of all strokes and is caused by blockage of the arteries that supply blood to the brain


    Researchers found that after a stroke, the level of IAIP naturally produced in mice and humans decreases


    Importantly, even if IAIP is delayed 4.


    The combination of IAIP and tissue plasminogen activator (t-PA) is also the most effective in mice.


    Journal Reference :

    1. Louise D.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.